NHC EVP and COO Marc Boutin spoke about the MODDERN Cures Act at the Rare Disease Congressional Caucus Briefing on November 14, 2012.
NHC Executive Vice President and COO Marc Boutin discusses the impact of the Congressional and Presidental elections on federal initiatives affecting patients.
NHC EVP and COO Marc Boutin spoke at the October 11, 2012, Health Affairs briefing on "Current Challenges in Comparative Effectiveness Research." After the briefing, Boutin participated in three short interviews with NHC member the National Pharmaceutical Council (NPC).
NHC Executive Vice President and Chief Operating Officer Marc Boutin discussed benefit-risk from a patient perspective. He was a speaker on the Webinar, "Do Innovative Products Need Innovative Reviews? Perspectives on Innovation in a Data-Driven World." To skip to his comments, move the button below the video screen to the time of 26.23 (audio file).
NHC Executive Vice President and Chief Operating Officer Marc Boutin discussed federal policy and medical innovation from the patient perspective. He was a panelist at a Washington Post Live symposium on Advancing Medical Innovation.
The National Health Council (NHC) was honored by the National Marfan Foundation (NMF) with NMF's 2012 Health Media Award. Presented at NMF's 27th Annual Conference, the award recognizes the NHC and WebMD for the creation of the blog A Different Normal: Living with a Chronic Condition.
Here. Us. Now. A Family's Fight to Bring Medical Innovation Home. This documentary includes comments from NHC Executive Vice President and Chief Operating Officer Marc Boutin.
Marc Boutin, NHC's Executive Vice President and Chief Operating Officer, discusses the importance of an FDA benefit-risk balance that meets the needs of patients on BioCentury TV.
Marc Boutin discusses the importance of understanding patients' core needs and building an effective healthcare strategy based on that understanding.
NHC President Myrl Weinberg spoke at the Fourth Annual Sentinel Initiative Public Workshop about managing expectations and communicating findings of Sentinel.
NHC President Myrl Weinberg served as the moderator for the National Congress on Health Care Clinical Innovation and Cost Containment seminar entitled Consumer Engagement and Accessibility of Health Information.
National Health Council briefing on the creation of a national essential health benefits package.
NHC Executive Vice President and COO Marc Boutin testimony to the House of Representatives Subcommittee on Health hearing on PDUFA V: Medical Innovation, Jobs, and Patients.
BioCentury This Week features an interview with NHC Executive Vice President and COO Marc Boutin on a proposal to promote personalized health care, create a new category of drugs called dormant therapies, and encourage the development of treatments and cures for patients with unmet medical needs.
NHC President Myrl Weinberg and Alzheimer's Association President and CEO Harry Johns take part in a panel discussion on Behavioral Economics: The Role of Patients and Caregivers in Health Care. To start the session, move the button below the viewing screen to the time mark of 30:22.
BioCentury This Week features NHC Executive Vice President and COO Marc Boutin commenting on comparative effectiveness research and drug safety.
NHC Executive Vice President and COO Marc Boutin spoke at a Patient Partnership to Improve Patient Care (PIPC) briefing: Delivering on Patient-Centered Care.
NHC Executive Vice President and COO Marc Boutin spoke at a roundtable discussion hosted by the Federal Trade Commission. He was part of a panel focusing on privacy issues related to health information.
The Spondylitis Association and Dr. Eric Roter, an emergency medicine physician in Cleveland and a Juilliard trained cellist, teamed up to produce a creative video in support of the NHC and the Campaign to Put Patients First.
NHC Executive Vice President and COO Marc Boutin spoke at a congressional briefing hosted by the Council for American Medical Innovation. He was part of a panel discussing the impact of public policy on America's pipeline of innovative treatments. Click here to view his presentation, which begins approximately 9 minutes into the video. A full summary of the briefing is also available online.